36 reports

  • GLOBAL SEXUAL DYSFUNCTION DRUGS MARKET SEGMENTATION BY THERAPY 2016
  • GLOBAL SEXUAL DYSFUNCTION DRUGS MARKET 2016-2021 ($ MILLIONS)
  • Dysfunction Drug
  • Forecast
  • AbbVie Inc.
  • Eli Lilly & Co.
  • Pfizer Inc.
  • Global erectile dysfunction treatment market by product
  • Global ED treatment market by product 2015 and 2020
  • Dysfunction Drug
  • Boston Scientific Corporation
  • Coloplast Group
  • Eli Lilly & Co.
  • Pfizer Inc.
  • Erectile Dysfunction - Overview
  • Erectile Dysfunction - Therapeutics Assessment
  • Dysfunction Drug
  • Pharmaceutical
  • United States
  • Product Initiative
  • Apricus Biosciences, Inc.
  • Erectile Dysfunction - Dormant Projects
  • Erectile Dysfunction - Discontinued Products
  • Dysfunction Drug
  • Pharmaceutical
  • United States
  • Product Initiative
  • Apricus Biosciences, Inc.

Key Features of the Report: - Erectile Dysfunction Patient Flow - Erectile Dysfunction Prevalence - Erectile Dysfunction Diagnosed Patients - Erectile Dysfunction Treated Patients

  • Dysfunction Drug
  • Therapy
  • Europe
  • World
  • Forecast

Marketed Drugs for Erectile Dysfunction, US, 2016 ##.

  • Dysfunction Drug
  • France
  • Germany
  • Italy
  • Japan

It also provides a comprehensive understanding of the emerging Phase III therapies for Erectile Dysfunction which can turn out to be future prospective competitors for the marketed products.

  • Dysfunction Drug
  • Therapy
  • World
  • Demand
  • Product Initiative

Erectile dysfunction Pipeline by Drug Class ##.

  • Dysfunction Drug
  • Therapy
  • Product Initiative

Key Features of the Report: - Erectile Dysfunction Patient Flow - Erectile Dysfunction Prevalence - Erectile Dysfunction Diagnosed Patients - Erectile Dysfunction Treated Patients

  • Dysfunction Drug
  • Europe
  • France
  • Germany
  • Forecast
  • FEATURES OF ERECTILE DYSFUNCTION PATIENTS
  • Prevalence of Erectile Dysfunction, males (000s)
  • Dysfunction Drug
  • Pharmaceutical
  • Therapy
  • Europe

US Market Report for Erectile Dysfunction Devices 2016 - MedCore TABLE OF CONTENTS I LIST OF FIGURES III LIST OF CHARTS IV EXECUTIVE SUMMARY ## ##. ## U. S.

  • Dysfunction Drug
  • Therapy
  • United States

Male and Female Sexual Dysfunctions: Drug Market Report and Forecasts 2016-2026 ##.

  • Dysfunction Drug
  • Pharmaceutical
  • Therapy
  • World
  • Market Size

Marketed Drugs for Erectile Dysfunction, UK, 2016 ##.

  • Dysfunction Drug
  • Europe
  • France
  • Germany
  • Italy

Japan Erectile Dysfunction Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Erectile Dysfunction Treatments ##) Erectile Dysfunction Pipeline ##) Japan Erectile

  • Dysfunction Drug
  • Therapy
  • Japan
  • Market Shares

UK Erectile Dysfunction Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Erectile Dysfunction Treatments ##) Erectile Dysfunction Pipeline ##) UK Erectile

  • Dysfunction Drug
  • Therapy
  • United Kingdom
  • Market Shares

Italy Erectile Dysfunction Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Erectile Dysfunction Treatments ##) Erectile Dysfunction Pipeline ##) Italy Erectile

  • Dysfunction Drug
  • Therapy
  • Italy
  • Market Shares

Germany Erectile Dysfunction Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Erectile Dysfunction Treatments ##) Erectile Dysfunction Pipeline ##) Germany Erectile

  • Dysfunction Drug
  • Therapy
  • Germany
  • Market Shares

France Erectile Dysfunction Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Erectile Dysfunction Treatments ##) Erectile Dysfunction Pipeline ##) France Erectile

  • Dysfunction Drug
  • Therapy
  • France
  • Market Shares

US Erectile Dysfunction Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Erectile Dysfunction Treatments ##) Erectile Dysfunction Pipeline ##) US Erectile

  • Dysfunction Drug
  • Therapy
  • Market Shares

Spain Erectile Dysfunction Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Erectile Dysfunction Treatments ##) Erectile Dysfunction Pipeline ##) Spain Erectile

  • Dysfunction Drug
  • Therapy
  • Spain
  • Market Shares

The total market for erectile dysfunction treatment devices includes inflatable erectile dysfunction devices and malleable erectile dysfunction devices.

  • Dysfunction Drug
  • Therapy
  • Europe
  • Female Sexual Dysfunction - Drug Profiles
  • SMALL MOLECULE FOR SEXUAL DYSFUNCTION - DRUG PROFILE
  • Dysfunction Drug
  • United States
  • Litigation And Patent
  • Product Initiative
  • Palatin Technologies, Inc.
  • SMALL MOLECULE FOR SEXUAL DYSFUNCTION - DRUG PROFILE
  • SMALL MOLECULES TO AGONIZE DOPAMINE D2 RECEPTOR FOR SEXUAL DYSFUNCTION - DRUG PROFILE
  • Dysfunction Drug
  • Therapy
  • United States
  • Product Initiative
  • Apricus Biosciences, Inc.
  • 4.2 Erectile Dysfunction
  • 7.2 Erectile Dysfunction
  • Dysfunction Drug
  • United States
  • Company
  • Product Initiative
  • Mezzion Pharma Co., Ltd.

The primary treatment for erectile dysfunction is Viagra or a similar-acting drug.

  • Dysfunction Drug
  • Prosthesis
  • Therapy
  • World
  • Forecast
  • Futura Medical Plc, Major Products and Services
  • Consumer Healthcare (GSK) for the development of TPR100.
  • Dysfunction Drug
  • Healthcare
  • United States
  • Company Financials
  • Futura Medical plc
  • INTELGENX ENTERS INTO DEVELOPMENT AND COMMERCIALIZATION AGREEMENT WITH PAR PHARMA
  • INTELGENX ENTERS INTO LICENSING AGREEMENT WITH ELI LILLY AND COMPANY

IntelGenx products are indicated for the treatment of migraine, opioid dependence, erectile dysfunction, schizophrenia, pain management, central nervous system, respiratory, cardiovascular and depressive disorders indications, among other.

  • Dysfunction Drug
  • Canada
  • United States
  • Company
  • IntelGenx Corp.
  • VIVUS, INC.: REGULATORY AND LEGAL EVENTS
  • VIVUS, INC.: RECENT DEVELOPMENTS
  • Dysfunction Drug
  • Pharmaceutical
  • United States
  • Company
  • VIVUS, Inc.
  • Official Title
  • Clinical Trial profile. 278 Trial Title
  • Clinical Trial
  • Dysfunction Drug
  • Pharmaceutical
  • World
  • Product Initiative
  • Licensing and Collaboration
  • Futura Medical Plc - Pipeline by Indication, 2015
  • Dysfunction Drug
  • Pharmaceutical
  • R&D
  • Research And Development
  • Therapy